Wall St rallies as Pfizer gets full FDA approval, Why Kogan is bullish: ASX to edge higher
24 Aug 2021 - Global stocks claw their way back into positive territory as oil prices recovered, while investors buy the dip. U.S. FDA gives full approval for Pfizer boosting Wall St’s performance. Asian & European markets marched their way back. Why Kogan (ASX:KGN) is bullish for Stock Watch.